[Mediastinal large B-cell lymphoma].
Mediastinal B-cell lymphoma is a locally highly aggressive tumour which was first described in the early 1980s. The incidence is about 2-3% of all non-Hodgkin's lymphomas. The conceptional evolution of this lymphoma entity was hampered by its low incidence and the broad spectrum of morphological variants present. However, since mediastinal B-cell lymphoma has distinct morphological, immunological, genetic, and clinical features, it has been listed in the revised European-American Classification of Lymphoid Neoplasms (REAL-Classification) since 1994 as a variant of diffuse large B-cell lymphoma. In the World Health Organization classification of malignant lymphomas, mediastinal B-cell lymphoma is now listed with an own disease code (ICD-9679/3).
Barth
T F E
TF
Institut für Pathologie, Universität Ulm.
Möller
P
P
D006801:Humans; D016130:Immunophenotyping; D015994:Incidence; D016393:Lymphoma, B-Cell / Q000453:epidemiology / Q000276:immunology / Q000473:pathology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000453:epidemiology / Q000276:immunology / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000453:epidemiology / Q000473:pathology; D008479:Mediastinal Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000473:pathology*; D009367:Neoplasm Staging